Healthtech Companies

Healthtech consulting grounded in how GCC providers work

Market access, provider partnerships and regulatory context for healthtech in the GCC.

Healthtech founders often build strong products that stall when they meet real providers. Buying decisions involve medical directors, finance teams and IT, and adoption depends on fitting into existing workflows, payer rules and national platforms. Our healthtech consulting helps founders understand that environment before they spend heavily on market entry.

Tulazai Health brings the provider side of the table. With 18+ years in hospital operations, revenue cycle and insurance networking, we help healthtech companies shape their proposition, test it against provider workflows, prepare for regulatory conversations and find suitable pilot partners in the UAE and wider GCC.

What gets in the way

The challenges we see most

01

Products that do not fit provider workflows

A tool that adds clicks for doctors or front desk staff will struggle, however good the technology. Understanding daily clinical and administrative routines is essential for adoption.

02

Complex national platforms and integrations

E-claims platforms, health information exchanges and electronic records systems differ by emirate and country. Products touching claims or records must work within these environments.

03

Long and unclear sales cycles

Provider purchasing involves several decision makers and often a pilot. Without the right contacts and a clear business case, sales cycles stretch and early funding is consumed.

04

Regulatory and data expectations

Health data, telehealth and medical device rules vary across the GCC. Founders need a realistic view of what approvals and safeguards apply before they promise launch dates.

Frequently asked questions

How does healthcare consulting help a healthtech company?
Healthtech consulting from a provider perspective helps you see your product the way a hospital or clinic will. We review workflow fit, the business case for buyers, integration expectations and regulatory context, and we help shape pilots that produce credible evidence. This shortens the learning curve that usually happens during slow, expensive early sales.
Can you introduce us to hospitals and clinics for pilots?
Where there is a genuine fit, we can help identify suitable providers and structure a pilot proposal they can evaluate. We do not sell introductions for their own sake. A pilot works best when the problem, the success measures and the responsibilities on both sides are clear from the start.
Do you advise on health data and telehealth regulation?
We provide an operational overview of the regulatory landscape and the questions you will need to answer, including telehealth licensing and health data handling in the markets you are targeting. For formal legal opinions on data protection or device classification, we recommend working with a qualified legal advisor alongside us.
Is the UAE or Saudi Arabia a better first market for healthtech?
Both are attractive but very different. The UAE offers a concentrated, highly insured private market with emirate-level regulators, while Saudi Arabia offers scale and a large transformation programme with national platforms. The right first market depends on your product, your buyers and your resources, and we help you compare them honestly.

Complimentary 30-minute call

Talk it through with Dr. Neeraj.

Tell us where your facility is today and where you want it to be. You leave the call with a clear next step.